IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
Home Page: www.novartis.com.au
Sub sid iary of: Novartis, Swit zer land (100%)
SANDOZ
Full Name: Sandoz Aus tra lia Pty Ltd
Street Ad dress: Level 4, Suite 7-19, 100 Har ris
St., Pyr mont, NSW 2009
Tel: +61 2 9566 1500
Fax: +61 2 9566 1458
De scrip tion: Man u fac turer, packager/as sem -
bler, im porter, dis trib u tor, pro moter,
sales/detailer. Prod uct ranges in clude: phar ma -
ceu ti cal prod ucts (branded, pre scrip tion), bi o log i -
cal prod ucts. Es tab lished 2005. 100
phar ma ceu ti cal employees in 2007.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 51-100 (2007)
Con tacts (Pharm): Chair man: John Stokes;
Gen eral Con tact: Rene Llewellyn
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 95-100 mil lion
Prod ucts (% of Sales by Lead ing 5): 30-35%
Ther a peu tic Classes (% of Sales by Lead ing
5): 60-65%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
SIMVAHEXAL (cho les terol/triglyceride reg u lat ing
prep a ra tion)
PROBITOR (antiulcerant)
HEXAL METARAMINOL (car diac stim u lant
non-glycoside)
RAMIPRIL SANDOZ (ACE in hib i tor plain)
MEPRAZOL (antiulcerant)
Ther a peu tic Range:
lipid-reg u lat ing/antiatheroma prep a ra tions
18%
antibacterials sys temic 15%
ant ac ids/antiflatulents/antiulcerants 13%
psychoanaleptics 11%
renin-an gio ten sin sys tem agents 6%
Lead ing Dose Forms:
tab lets 58%
cap sules 17%
coated tab lets 10%
vi als 7%
am poules 6%
AUSTRIA
HEXAL
Full Name: Hexal Pharma GmbH
Street Ad dress: Carlbergergasse 44, A-1235
Wien
Tel: +43 1 866 59 9350
Fax: +43 1 486 96 22-9344
Email: of fice@hexal.at
Home Page: www.hexal.at
De scrip tion: Im porter, dis trib u tor, pro moter,
sales/detailer. Prod uct ranges in clude: phar ma -
ceu ti cal prod ucts (branded, unbranded, pre scrip -
tion, non-pre scrip tion), hos pi tal pharmaceuticals,
di ag nos tic prod ucts, oph thal mic prod ucts. Es tab -
lished 1997. 35 phar ma ceu ti cal employees in
2008.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 21-50 (2008)
Con tacts (Pharm): Chair man: Elgar Schnegg;
Com mer cial Op er a tions: Guenter Gaspari; Mar ket
Re search: Elis a beth Zoehling; Re search & De vel -
op ment: Cornelia Wetton; Gen eral Con tact: Elis a -
beth Zoehling
Par ent of: 1A Pharma, Aus tria (100%).
Sub sid iary of: Sandoz, Aus tria
Phar ma ceu ti cal Sales: US$ 50-55 mil lion
Prod ucts (% of Sales by Lead ing 5): 45-50%
Ther a peu tic Classes (% of Sales by Lead ing
5): 65-70%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
OMEC (antiulcerant)
CARVEDILOL-HEXAL (beta-blocker agent plain)
SIMVASTATIN-HEXAL (cho les terol/triglyceride
reg u lat ing prep a ra tion)
CO-ENAC (ACE in hib i tor com bi na tion)
AMLODIPIN-HEXAL (cal cium an tag o nist plain)
Ther a peu tic Range:
ant ac ids/antiflatulents/antiulcerants 20%
renin-an gio ten sin sys tem agents 17%
beta-block ing agents 10%
psychoanaleptics 10%
lipid-reg u lat ing/antiatheroma prep a ra tions
10%
Lead ing Dose Forms:
tab lets 47%
coated tab lets 28%
cap sules 20%
med i cal dress ings 4%
liq uids 2%
NOVARTIS
Full Name: Novartis Pharma GmbH
© 2009 IMS Health In cor po rated or its af fil i ates Page 150